Brief: Enochian Biosciences On June 20 Entered Into Purchase Agreement With Lincoln Park Capital Fund
June 27 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES INC- ON JUNE 20, ENTERED INTO
PURCHASE
AGREEMENT WITH LINCOLN PARK CAPITAL FUND, LLC
* ENOCHIAN BIOSCIENCES -AS PER DEAL, CO MAY SELL TO LINCOLN
PARK
UP TO $20 MILLION SHARES OF COMMON STOCK PAR VALUE $0.0001 PER
SHARE OVER 36 MONTH TERM
Further company coverage: ENOB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing